H.C. Wainwright initiated coverage on Rain Therapeutics with a new price target
$RAIN
Industrial Machinery/Components
Technology
H.C. Wainwright initiated coverage of Rain Therapeutics with a rating of Buy and set a new price target of $10.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/30/2023 | Buy → Neutral | ROTH MKM | |
| 3/21/2023 | $11.00 | Outperform | SVB Securities |
| 1/31/2023 | $21.00 | Buy | ROTH Capital |
| 1/23/2023 | $18.00 | Buy | Mizuho |
| 9/12/2022 | $10.00 | Buy | H.C. Wainwright |
| 4/1/2022 | $15.00 | Outperform | Oppenheimer |
| 9/14/2021 | $22.00 | Neutral | Goldman |
| 7/20/2021 | $25.00 | Overweight | Piper Sandler |
ROTH MKM downgraded Rain Oncology from Buy to Neutral
SVB Securities initiated coverage of Rain Oncology with a rating of Outperform and set a new price target of $11.00
ROTH Capital resumed coverage of Rain Oncology with a rating of Buy and set a new price target of $21.00
424B3 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Filer)
10-Q - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Filer)
SCHEDULE 13G - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Subject)
3 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
3 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)
4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)